Original: $150.00
-70%$150.00
$45.00The Story
• Composition and format
BPC-157 (1 mg) is a synthetic pentadecapeptide supplied as 1 mg per tablet, with 60 tablets per container for controlled laboratory workflows using solid-format test articles. The batch-specific Certificate of Analysis (COA) details identity, peptide content per unit, physical form, and relevant excipient information, supporting method-level reproducibility, mass-balance calculations, and documentation control in research settings.
• Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
• Intended research use
BPC-157 is evaluated in controlled in-vitro systems investigating peptide-mediated signaling, including models of angiogenic pathway activation, extracellular matrix regulation, and cell-communication networks. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
This synthetic peptide is characterized for use as a research reagent in analytical and cell-based models examining peptide-driven modulation of signaling cascades, matrix-associated processes, and related molecular feedback loops. Researchers employ BPC-157 in defined in-vitro environments to study concentration-response relationships, pathway mapping, and interaction profiles with cellular targets, strictly within laboratory assay designs and not in any in-vivo context.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
Description
• Composition and format
BPC-157 (1 mg) is a synthetic pentadecapeptide supplied as 1 mg per tablet, with 60 tablets per container for controlled laboratory workflows using solid-format test articles. The batch-specific Certificate of Analysis (COA) details identity, peptide content per unit, physical form, and relevant excipient information, supporting method-level reproducibility, mass-balance calculations, and documentation control in research settings.
• Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
• Intended research use
BPC-157 is evaluated in controlled in-vitro systems investigating peptide-mediated signaling, including models of angiogenic pathway activation, extracellular matrix regulation, and cell-communication networks. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
This synthetic peptide is characterized for use as a research reagent in analytical and cell-based models examining peptide-driven modulation of signaling cascades, matrix-associated processes, and related molecular feedback loops. Researchers employ BPC-157 in defined in-vitro environments to study concentration-response relationships, pathway mapping, and interaction profiles with cellular targets, strictly within laboratory assay designs and not in any in-vivo context.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
